C. Wilkens

Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement.

H. Hawighorst, P. G. Knapstein, W. Weikel et al. · PubMed · 1997 · 143 citations

Medicine, Oncology, Radiology +17

Usefulness of Immunohistochemical Staining for p53 in the Prognosis of Breast Carcinomas: Correlations with Established Prognosis Parameters and with the Proliferation Marker, MIB-1

Thomas Beck, E Weller, W. Weikel et al. · Gynecologic Oncology · 1995 · 45 citations

Medicine, Oncology, Pathology +17

Immunohistochemical Detection of Hormone Receptors in Breast Carcinomas (ER-ICA, PgR-ICA): Prognostic Usefulness and Comparison with the Biochemical Radioactive-Ligand-Binding Assay (DCC)

Thomas Beck, W. Weikel, C. Brumm et al. · Gynecologic Oncology · 1994 · 44 citations

Medicine, Endocrinology, Oncology +17

C-myc mRNA Expression in Epithelial Ovarian Carcinomas in Relation to Estrogen Receptor Status, Metastatic Spread, Survival Time, FIGO Stage, and Histologie Grade and Type

B. Tanner, Jan G. Hengstler, Andreas Luch et al. · International Journal of Gynecological Pathology · 1998 · 20 citations

Medicine, Gynecology, Oncology +16

Growth fractions (Ki-67) in primary breast cancers, with particular reference to node-negative tumors.

W. Weikel, C. Brumm, C. Wilkens et al. · PubMed · 1995 · 20 citations

Medicine, Oncology, Pathology +15